OncoSec is a New Jersey-based biotechnology company that researches and develops cytokine-based intratumoral immunotherapies for the treatment of cancer.
Business Model:
Revenue: $47.5M
Employees: 11-50
Address: 24 N Main Street
City: Pennington
State: NJ
Zip: 08534
Country: US
OncoSec is a New Jersey-based biotechnology company that researches and develops cytokine-based intratumoral immunotherapies for the treatment of cancer.
Contact Phone:
+18556626732
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/7/2010
Ticker Symbol:
ONCS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2019 | Post-IPO Equity | $11M | 11/2022 | Post-IPO Equity | $3.5M | 1/2021 | Post-IPO Equity | $42M | 10/2014 | Grant | 1 | $163k |
National Institutes of Health National Institutes of Health |
12/2022 | Post-IPO Equity | $3.5M | 4/2020 | Debt | $350k |
U.S. Small Business Administration. |
7/2011 | Post-IPO Equity | $3M | 6/2014 | Post-IPO Equity | $16M | 9/2013 | Post-IPO Equity | $12M | 2/2018 | Post-IPO Equity | $23M | 9/2018 | Post-IPO Equity | $0 |
Alpha Holdings Alpha Holdings Alpha Holdings Alpha Holdings |
10/2019 | Equity | $30M | 12/2018 | Equity | $7M |
Alpha Holdings, Inc. |
9/2018 | Equity | $8M |
Alpha Holdings, Inc. |
6/2015 | Post-IPO Equity | $13.6M | 9/2018 | Post-IPO Equity | 1 | $15M |
Alpha Holdings Alpha Holdings Alpha Holdings Alpha Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|